Nature Communications (Apr 2019)

Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition

  • Lei Gao,
  • Yong Hu,
  • Yahui Tian,
  • Zhenzhen Fan,
  • Kun Wang,
  • Hongdan Li,
  • Qian Zhou,
  • Guandi Zeng,
  • Xin Hu,
  • Lei Yu,
  • Shiyu Zhou,
  • Xinyuan Tong,
  • Hsinyi Huang,
  • Haiquan Chen,
  • Qingsong Liu,
  • Wanting Liu,
  • Gong Zhang,
  • Musheng Zeng,
  • Guangbiao Zhou,
  • Qingyu He,
  • Hongbin Ji,
  • Liang Chen

DOI
https://doi.org/10.1038/s41467-019-09295-7
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 15

Abstract

Read online

The tumor suppressor GATA4 is frequently epigenetically silenced in lung cancer. In this study, Gao et al. demonstrate that GATA4 regulates the expression of TGFBR2 and that TGFRB1 inhibitors can synergise with chemotherapeutics to inhibit the growth of GATA4-deficient tumors in mice.